SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is seeing significant momentum as investors pivot toward its unique treasury model, which holds a substantial position in the HYPE token. The community is actively discussing the stock's potential for a squeeze driven by institutional interest, heavy volume, and the ongoing integration of perpetual trading infrastructure into traditional markets.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending as the community anticipates their upcoming earnings report, with investors weighing the company's recent government contract wins and AI networking growth against concerns over margin pressures. Discussion is dominated by debates on whether HPE can successfully capitalize on the AI infrastructure supercycle or if it will continue to lag behind primary industry competitors.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The firm's solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Its customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. The firm's regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. Its customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is drawing significant investor attention due to its strong economic moat in life sciences software and the strategic integration of AI to drive operational efficiencies. While some market participants debate the competitive landscape following the company's separation from Salesforce, others view the stock as a compelling long-term opportunity, particularly as it continues to win major biopharma contracts and benefits from its recent inclusion in the S&P 500.

AIRO Group Holdings, Inc. engages in the purpose of acquiring and integrating various companies engaged in the aerospace and defense industry. It operates through the following segments: Avionics and Electronics, Electric Air Mobility, Drones, and Training. The Avionics and Electronics segment refers to its brand, Aspen Avionics, which designs, certifies, and manufactures critical navigation, communication, and display components and integrated systems. The Electric Air Mobility segment transforms urban transportation with its development of an electric vertical take-off and landing (eVTOL) aircraft. The Drones perform crucial missions such as ISR and target tracking, mapping, surveying, inspection, and localization, enhancing military, and commercial operational efficiency worldwide. The Training segment relates to its brand, Coastal Defense, delivers specialized professional training services to the military and commercial aviation communities. The company was founded by Chirinjeev Kathuria on August, 30, 2021 and is headquartered in McLean, VA.

AIRO Group Holdings Inc.

Airo Group Holdings Inc

AIRO is capturing significant attention as the drone sector surges on the back of rising global defense spending and the ongoing integration of autonomous technologies into modern conflict. Investors are actively debating the company's valuation relative to peers and monitoring potential catalysts, including expansion into high-speed interceptor drone platforms and upcoming earnings reports.

Memecoin on Injective taken over by the community.

Nonja

The Nonja ($NONJA.X) community is actively rallying behind the token as a high-beta, leverage-style play on the Injective ($INJ.X) ecosystem, driven by strong sentiment regarding the chain's institutional adoption and recent tokenomics updates. Holders are highly focused on the project's burned liquidity as a rug-protection feature and are positioning for potential exponential gains as broader market interest in Injective's fundamental growth continues to build.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following the publication of positive Phase 3 results for daraxonrasib in metastatic pancreatic cancer, which demonstrated an unprecedented improvement in overall survival compared to standard chemotherapy. While the community is actively discussing the potential for a major buyout or expedited FDA approval, sentiment remains focused on the drug's role as a potential new standard of care in a difficult-to-treat disease.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as community members highlight its perceived role in institutional banking infrastructure and real-world asset tokenization. Discussions are heavily focused on the coin's limited supply, its potential for long-term utility in the finance sector, and speculation regarding upcoming developments like staking.

Chip

Chip is driving significant community debate as traders split between those betting on its utility as a GPU-backed lending protocol and those labeling it a pump-and-dump scheme due to persistent downward price action. Investors are closely watching the token's volatility and volume while navigating concerns over insider selling and structural tokenomics.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors closely monitor clinical developments for ivonescimab, particularly following its selection for a prestigious ASCO plenary session which has sparked optimism over its potential to challenge industry benchmarks. The community remains hyper-focused on upcoming regulatory milestones and ongoing trial data, fueling active debates around the company's valuation, potential partnership opportunities, and its long-term competitive position in the oncology space.

Zoracles

Zoracles is seeing active community discussion as traders monitor its price action relative to broader crypto market volatility and upcoming ecosystem catalysts. Many investors are currently focused on potential accumulation opportunities, debating whether the token is undervalued while waiting for technical indicators to signal a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
